Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment

Show simple item record

dc.contributor.author Halpern, Alfredo
dc.contributor.author Mancini, Marcio C.
dc.contributor.author Magalhaes, Maria Eliane C.
dc.contributor.author Fisberg, Mauro [UNIFESP]
dc.contributor.author Radominski, Rosana
dc.contributor.author Bertolami, Marcelo C.
dc.contributor.author Bertolami, Adriana
dc.contributor.author Melo, Maria Edna de
dc.contributor.author Zanella, Maria Teresa [UNIFESP]
dc.contributor.author Queiroz, Marcia S.
dc.contributor.author Nery, Marcia
dc.date.accessioned 2016-01-24T14:05:20Z
dc.date.available 2016-01-24T14:05:20Z
dc.date.issued 2010-08-18
dc.identifier http://dx.doi.org/10.1186/1758-5996-2-55
dc.identifier.citation Diabetology & Metabolic Syndrome. London: Biomed Central Ltd, v. 2, 20 p., 2010.
dc.identifier.issn 1758-5996
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/32825
dc.description.abstract Overweight and obesity in youth is a worldwide public health problem. Overweight and obesity in childhood and adolescents have a substantial effect upon many systems, resulting in clinical conditions such as metabolic syndrome, early atherosclerosis, dyslipidemia, hypertension and type 2 diabetes (T2D). Obesity and the type of body fat distribution are still the core aspects of insulin resistance and seem to be the physiopathologic links common to metabolic syndrome, cardiovascular disease and T2D. the earlier the appearance of the clustering of risk factors and the higher the time of exposure, the greater will be the chance of developing coronary disease with a more severe endpoint. the age when the event may occur seems to be related to the presence and aggregation of risk factors throughout life.The treatment in this age-group is non pharmacological and aims at promoting changes in lifestyle. However, pharmacological treatments are indicated in special situations. the major goals in dietary treatments are not only limited to weight loss, but also to an improvement in the quality of life. Modification of risk factors associated to comorbidities, personal satisfaction of the child or adolescent and trying to establish healthy life habits from an early age are also important. There is a continuous debate on the best possible exercise to do, for children or adolescents, in order to lose weight. the prescription of physical activity to children and adolescents requires extensive integrated work among multidisciplinary teams, patients and their families, in order to reach therapeutic success.The most important conclusion drawn from this symposium was that if the growing prevalence of overweight and obesity continues at this pace, the result will be a population of children and adolescents with metabolic syndrome. This would lead to high mortality rates in young adults, changing the current increasing trend of worldwide longevity. Government actions and a better understanding of the causes of this problem must be implemented worldwide, by aiming at the prevention of obesity in children and adolescents. en
dc.format.extent 20
dc.language.iso eng
dc.publisher Biomed Central Ltd
dc.relation.ispartof Diabetology & Metabolic Syndrome
dc.rights Acesso aberto
dc.title Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment en
dc.type Resenha
dc.contributor.institution Universidade de São Paulo (USP)
dc.contributor.institution Universidade do Estado do Rio de Janeiro (UERJ)
dc.contributor.institution Universidade Federal de São Paulo (UNIFESP)
dc.contributor.institution Universidade Federal do Paraná (UFPR)
dc.contributor.institution São Paulo State Hlth Dept
dc.description.affiliation São Paulo Univ HC FMUSP, Grp Obes & Metab Syndrome, Endocrinol & Metab Serv, Hosp Clin,Fac Med, São Paulo, Brazil
dc.description.affiliation State Univ Rio de Janeiro UERJ, Hosp Univ Pedro Ernesto, Arterial Hypertens & Lipids Sector, Rio de Janeiro, Brazil
dc.description.affiliation Fed Univ São Paulo UNIFESP, Dept Pediat, Adolescent Ctr, São Paulo, Brazil
dc.description.affiliation Fed Univ Parana UFPR, Endocrinol & Metab Serv, Hosp Clin, Dept Nutr, Curitiba, Parana, Brazil
dc.description.affiliation São Paulo State Hlth Dept, Dante Pazzanese Inst Cardiol, São Paulo, Brazil
dc.description.affiliation Fed Univ São Paulo UNIFESP, Dept Med, Serv Endocrinol, São Paulo, Brazil
dc.description.affiliation São Paulo Univ HC FMUSP, Grp Diabet, Endocrinol & Metab Serv, Hosp Clin,Fac Med, São Paulo, Brazil
dc.description.affiliationUnifesp Fed Univ São Paulo UNIFESP, Dept Pediat, Adolescent Ctr, São Paulo, Brazil
dc.description.affiliationUnifesp Fed Univ São Paulo UNIFESP, Dept Med, Serv Endocrinol, São Paulo, Brazil
dc.identifier.file WOS000290262700001.pdf
dc.identifier.doi 10.1186/1758-5996-2-55
dc.description.source Web of Science
dc.identifier.wos WOS:000290262700001



File

Name: WOS000290262700001.pdf
Size: 600.3Kb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account